Clinical Trial Update: Safety and Effectiveness of Evinacumab for the Treatment of Homozygous Familial Hypercholesterolemia [Phase 3]

View source ↗

Summary

This Phase 3 trial update reports safety and effectiveness data for evinacumab in Homozygous Familial Hypercholesterolemia; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homozygous Familial Hypercholesterolemia

Drugs mentioned

• Evkeeza (evinacumab)

Snippet

Sponsor: Daniel Gaudet | Conditions: Homozygous Familial Hypercholesterolemia | Phase 3 | Status: COMPLETED